![Mads Vindahl Kronborg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mads Vindahl Kronborg currently works at Evaxion Biotech A, as Vice President-Investor Relations & Communications.
Mr. Kronborg also formerly worked at H.
Lundbeck A, as Manager-Media Relations from 2011 to 2014, Zealand Pharma A, as Head-Investor Relations & Communications, and Scandion Oncology A, as Head-External Communications.
Postes actifs de Mads Vindahl Kronborg
| Sociétés | Poste | Début |
|---|---|---|
| EVAXION A/S | Investor Relations Contact | - |
Anciens postes connus de Mads Vindahl Kronborg
| Sociétés | Poste | Fin |
|---|---|---|
| ZEALAND PHARMA A/S | Investor Relations Contact | - |
| SCANDION ONCOLOGY A/S | Investor Relations Contact | - |
| H. LUNDBECK A/S | Public Communications Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Evaxion Biotech A/S
 Evaxion Biotech A/S BiotechnologyHealth Technology Develops novel vaccines | Health Technology |
Scandion Oncology A/S
 Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
Choisissez Zonebourse 
